Skip to main content
. 2017 Jan 31;12(1):e0171343. doi: 10.1371/journal.pone.0171343

Fig 2. APOBEC3B mRNA expression differences between primary breast tumors and paired metastases.

Fig 2

(A) APOBEC3B mRNA expression in primary breast tumors versus paired loco-regional and distant metastases. (B) APOBEC3B mRNA expression in primary breast tumors versus paired metastases, subdivided per location of metastasis (ovary (N = 4); liver (N = 6); bone (N = 4); brain (N = 14); lung (N = 5) and gastro-intestinal tract (N = 3). (C) APOBEC3B mRNA expression in ESR1-positive primary breast tumors versus paired distant and loco-regional metastases. (D) APOBEC3B mRNA expression in ESR1-negative primary breast tumors versus paired distant and loco-regional metastases. P-values obtained by paired Wilcoxon Signed Ranks test (2-tailed).